EDRUVIT

For prevention and treatment of vitamin deficiency in children and infants.

Nonspecific multivitamin preparations

Below 1 year : 9-10 drops (0.3 ml), 1 year and above : 23-25 drops (1.0 ml) once daily or as advised by the physicians.

Caution should be exercised when administering to patients on warfarin sodium-type anticoagulant therapy. In such patients, vitamin K may antagonize the hypothrombinemic response to anticoagulant drugs, such as warfarin and its congeners. Therefore, periodic monitoring of prothrombin/INR response is essential in determining the appropriate dosage of anticoagulant therapy. Patients receiving drugs that bind to a1-acid glycoprotein should be closely monitored for increases in response to these drugs, e.g. propranolol, prazosin and quinidine. Folic acid may increase the metabolism of some antiepileptics, such as phenobarbital, phenytoin and primidone. Pyridoxine can reduce the effect of levodopa. Bleomycin can be inactivated by ascorbic acid and riboflavin.

Supplemental vitamins should not be prescribed for patients with haemochromatosis or Wilson?s disease. Hypersensitivity to any of the ingredients is contraindicated. Excessive doses of vitamin A and D can lead to hypervitaminosis. When multivitamin preparations are prescribed allowance must be made for vitamins from other sources.

Multivitamin preparation with ordinary doses of component are usually nontoxic

No data available

The fat-soluble vitamins A, D, and E can accumulate to harmful levels. The possibility of hypervitaminosis A or D should be borne in mind. Clinical manifestations of hypervitaminosis A have been reported in patients with renal failure receiving 1.5 mg/day retinol. Therefore, vitamin A supplementation of renal failure patients should be undertaken with caution. Water-soluble vitamins are readily excreted in the urine. Treatment of vitamin overdosage usually consists of withdrawal of the vitamin.

Before reconstitution: Store below 25°C. Protect from light and do not freeze. After reconstitution: The reconstituted product should be used immediately or it should be stored at 2°C to 8°C for not more than 24 hours. Discard any unused portion of the reconstituted solution.

This is a lyophilized, sterile powder for injection/infusion which contains both water soluble and fat soluble vitamins. Each vial contains: Vitamin A BP 3500 IU Vitamin D3 BP 220 IU Vitamin E USP 11.2 IU Ascorbic Acid BP 125 mg Vitamin B1 BP 3.51 mg Vitamin B2 BP 4.14 mg Nicotinamide BP 46 mg Pantothenic Acid BP 17.25 mg Vitamin B6 BP 4.53 mg Vitamin B12 BP 6 mcg Folic Acid BP 414 mcg Biotin BP 69 mcg